Proteomics Market Set for Rapid Growth and
Trend by 2023
Global Proteomics Market Report 2019 explores future trends for
supply, demand and market growth rate, market size, prices, trading,
competition and value chain as well as Key Players of the industry’s
information with forecast from 2019 to 2023.
Global Proteomics Market Synopsis:
According to Market Analyst, The Global Proteomics Market is expected to grow at an impressive
Compound Annual Growth Rate (CAGR) from 2019 to 2023.
If you want to know more about Proteomics, Get Sample Copy of Report @
https://www.businessindustryreports.com/sample-request/142790 .
Proteome is an entire arrangement of proteins that is created by method for a machine or a living being.
It can go with fine time, necessities, focuses on, that a life cycle is going through. In light of the fact that
proteins are the helpful gadgets of cells, in this way proteomic answers every one of the inquiries
identified with it.
Growth of Proteomics Market is driven by increasing research activity in the area of personalized
medicine and drug discovery, increasing R&D expenditure by the pharmaceutical and biotechnology
sector, and rising government funding for proteomics.
The global Proteomics market can be segmented based on technology, reagent, Application, and region.
In terms of technology, the global Proteomics market is segmented into spectroscopy, chromatography,
electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, and protein
fractionation. The spectroscopy segment accounted for the largest market share in 2018.
Proteomics finds extensive applications in drug discovery, development of personalized medicines, and
identification of markers for disease diagnosis, which have escalated the growth of the proteomics
market in the past few years. With increase in awareness regarding the benefits of personalized
medicines, companies and government organizations have increased their R&D expenditure on the
development of proteomics.
Regionally, North America dominated the global proteomics market, followed by Europe. Increasing
investments in the development of structure-based drug designs, growing academic and government
investments in genomics and proteomics research are the factors propelling the growth of the market in
the region.